LQDA Liquidia Corp Company Cash Volume

liquidia.com - graphic logo of issuer LQDA

Liquidia Corporation (LQDA) is recognized as an innovator in pulmonary hypertension therapy due to its unique drug delivery systems. The cash balance history demonstrates financial resilience, where the 0.40 metric determines the liquidity parameter status. Growth in cash flow from core products is complemented by a cohesive biotech culture, driven by stock options and the significance of their mission to combat rare lung pathologies.

LQDA - Liquidia Corp Company Liquid Assets over the range 07/04/2022 - 11/21/2026

Financial and market metric breakdowns for Liquidia (LQDA)

- stock quotes and analyst forecast:
- cash availability and cash flow indicators:
Fundamental company analysis:LQDA Liquidia Corp
Product sample of liquidia.com

For the pulmonary hypertension therapy biotech leader Liquidia Corporation (LQDA), maintaining liquid reserves is critical for funding the costly development of innovative inhalers. Analyzing the free cash flow chart, an investor assesses the company's ability to sustain operations without external borrowing, where excess funds ensure financial stability but may signal insufficiently aggressive reinvestment into business expansion.

Competitors of Liquidia Corporation (LQDA)

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash Funds Galapagos N.V.|Company Cash on Hand ANI Pharmaceuticals, Inc. (ANIP)|Company Cash Volume MNKD|AMPH (Amphastar Corp) - Company Cash Balance|Company Cash Funds pacira.com PCRX|SPRY - Company Cash on Hand|Theravance Biopharma, Inc. - Company Cash Volume|Company Cash Balance AQST (Aquestive Therapeutics, Inc.)|SCPH: Company Cash Volume|Tectonic Therapeutic Inc. - Company Cash Balance|TNXP (Tonix Pharma) - Company Cash Volume|SXTC: Company Cash Balance|Company Cash Volume EPRX|BHST - Company Cash Reserve|eXoZymes - Company Cash on Hand|Company Cash Volume oramed.com ORMP|ENTX - Company Cash Funds|Company Liquid Assets MindWalk Holdings HYFT|ABVC: Company Cash Volume|Company Cash on Hand Cumberland Pharmaceuticals Inc.|Company Cash Funds Quantum BioPharma Limited|FGEN: Company Cash Balance|Company Cash Volume TELO|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance